| Drug-induced thrombocytopenic purpura | |
|---|---|
| Specialty | Dermatology |
Drug-induced thrombocytopenic purpura is a skin condition result from a low platelet count due to drug-induced anti-platelet antibodies caused by drugs such as heparin, sulfonamines, digoxin, quinine, and quinidine. [1]: 821
See also
References
- ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 978-0-7216-2921-6.
 | This cutaneous condition article is a stub. You can help Wikipedia by expanding it. |
| Drug-induced thrombocytopenic purpura | |
|---|---|
| Specialty | Dermatology |
Drug-induced thrombocytopenic purpura is a skin condition result from a low platelet count due to drug-induced anti-platelet antibodies caused by drugs such as heparin, sulfonamines, digoxin, quinine, and quinidine. [1]: 821
See also
References
- ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 978-0-7216-2921-6.
|
| This cutaneous condition article is a stub. You can help Wikipedia by expanding it. |